English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/206355
Share/Impact:
Statistics
logo share SHARE   Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Serotonin receptors: Implications for depression and its treatment

AuthorsCastañé, Anna ; Artigas, Francesc
Issue Date5-Jun-2019
Citation14th World Congress of Biological Psychiatry (2019)
AbstractObjective: Major depressive disorder (MDD) is a psychiatric syndrome with a high socioeconomic impact, due to its high prevalence and to the limited efficacy of treatments. Antidepressant efficacy depends, to a large extent, on the synaptic availability of serotonin (5-hydroxytryptamine; 5-HT) even for fast-acting strategies such as ketamine. However, blockade of the 5-HT transporter (SERT), as evoked by most antidepressant drugs (TCAs, SSRI, SNRI, etc.) is insufficient by itself to improve symptoms in many patients. The aim of the present talk is to describe the principal serotonergic mechanisms that facilitate or slow the antidepressant response.
DescriptionTrabajo presentado en el 14th World Congress of Biological Psychiatry, celebrado en Vancouver (Canadá), del 2 al 6 de junio de 2019
URIhttp://hdl.handle.net/10261/206355
Appears in Collections:(IIBB) Comunicaciones congresos
Files in This Item:
File Description SizeFormat 
Serotonin receptors_Castañe.pdf200,77 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.